Marlin & Associates, a boutique investment banking and strategic advisory firm, announced that the firm has been nominated and named a finalist as the Boutique Investment Bank of the Year.

Additionally, Marlin & Associates has been named a finalist for the five Deal-of-the-Year Awards:

  • M&A Deal-of-the-Year (between $500 million and $1 billion) for Marlin’s role advising Welsh, Carson, Anderson & Stowe and JMI Equity on its purchase of a majority interest in Triple Point Technology from ABRY Partners;

  • M&A Deal-of-the-Year (between $25 million and $50 million) for Marlin’s role advising Coalition Development (London, UK) on its sale to Credit Rating and Information Services of India, a subsidiary of McGraw-Hill;

  • Healthcare/Life Sciences Deal-of-the-Year (between $10 million and $100 million) for Marlin’s role advising NaviNet on its sale to Lumeris and three Blue Cross/Blue Shield organizations: Highmark, Horizon Blue Cross Blue Shield of New Jersey (Horizon), and Independence Blue Cross (IBC);

  • Financial Services Deal-of-the-Year for Marlin’s role advising IMS Research (Wellingborough, UK) on its sale to IHS, Inc.; and

  • Technology, Media, Telecom Deal-of-the-Year (between $10 million and $100 million) for Marlin’s role advising NYSE Euronext on its purchase of a minority interest in Fixnetix.

    The award winners will be revealed at the 11th Annual M&A Awards Gala at the New York Athletic Club in New York City on Dec. 11, 2012.

    The M&A Advisor, a conference producer and newsletter publisher serving the middle-market finance industry, facilitates connections and recognizes achievements in the top performers of the M&A, turnaround and financing industries.

    Marlin & Associates Holding is a boutique investment banking and strategic advisory firm specializing in acquisitions and divestitures of U.S. and international middle-market firms that provide technology, digital information and healthcare-related products, technology and services.